While management of locally advanced esophageal cancer has mostly involved multimodality therapy, management of clinical T2N0 patients has been more controversial, primarily as a result of inaccurate clinical staging with existing modalities. This review article examines current literature on this topic and provides recommendations for management of individual patients.
- Esophageal cancer
- Neoadjuvant therapy
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine